Acadia Healthcare price target lowered to $90 from $105 at BofA

BofA lowered the firm’s price target on Acadia Healthcare to $90 from $105 and keeps a Buy rating on the shares. The firm is raising EBITDA estimates following the quarterly report from the company, but lowering its target on shares despite the estimate raise given the higher debt to fund litigation settlements and potential for additional lawsuits, the analyst tells investors.